Patents by Inventor Edwin Homan

Edwin Homan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lipids that increase insulin sensitivity and methods of using the same
    Patent number: 11174216
    Abstract: The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: November 16, 2021
    Assignees: Beth Israel Deaconess Medical Center, Inc., President and Fellows of Harvard College
    Inventors: Barbara B. Kahn, Mark A. Herman, Alan Saghatelian, Edwin Homan, Mark M. Yore, Ismail Syed, Pedro M. M. Moraes Vieira
  • Lipids that increase insulin sensitivity and methods of using the same
    Patent number: 10604473
    Abstract: The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 31, 2020
    Assignees: Beth Israel Deaconess Medical Center, Inc., President and Fellows of Harvard College
    Inventors: Barbara B. Kahn, Mark A. Herman, Alan Saghatelian, Edwin Homan
  • Lipids That Increase Insulin Sensitivity And Methods Of Using The Same
    Publication number: 20180194714
    Abstract: The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 12, 2018
    Inventors: Barbara B. Kahn, Mark A. Herman, Alan Saghatelian, Edwin Homan, Mark M. Yore, Ismail Syed, Pedro M.M. Moraes Vieira
  • Lipids That Increase Insulin Sensitivity And Methods Of Using The Same
    Publication number: 20160221925
    Abstract: The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycystic ovarian syndrome, cancer, and inflammatory disorders—using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
    Type: Application
    Filed: March 14, 2014
    Publication date: August 4, 2016
    Inventors: Barbara B. KAHN, Mark A. HERMAN, Alan SAGHATELIAN, Edwin HOMAN
  • Lipids That Increase Insulin Sensitivity And Methods Of Using The Same
    Publication number: 20150133551
    Abstract: The invention provides, inter alia, fatty acyl hydroxy fatty acid (FAHFA; a novel class of estolide-related molecules) and diagnostic and treatment methods for a variety of disorders—including diabetes-related disorders, Metabolic Syndrome, polycyctic ovarian syndrome, cancer, and inflammatory disorders using them; as well as methods of screening for additional compounds that are useful in treating these disorders and/or that modulate FAHFA levels, FAHFA-mediated signaling, and FAHFA-mediated biological effects.
    Type: Application
    Filed: May 3, 2013
    Publication date: May 14, 2015
    Inventors: Barbara B. Kahn, Mark A. Herman, Alan Saghatelian, Edwin Homan